𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Synthesis and Biological Evaluation of Novel Cytotoxic Phospholipids for Prostate Cancer.

✍ Scribed by Veeresa Gududuru; Eunju Hurh; Gangadhar G. Durgam; Seoung Soo Hong; Vineet M. Sardar; Huiping Xu; James T. Dalton; Duane D. Miller

Publisher
John Wiley and Sons
Year
2005
Weight
150 KB
Volume
36
Category
Article
ISSN
0931-7597

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Synthesis and Biological Evaluation of N
Synthesis and Biological Evaluation of Novel Analogues and Prodrugs of the Cytotoxic Antibiotic CC-1065 for Selective Cancer Therapy
✍ LutzΒ F. Tietze; Tobias Herzig; Tim Feuerstein; Ingrid Schuberth πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 226 KB πŸ‘ 2 views

This paper describes novel seco-analogues 25-27 of the cytotoxic antibiotic CC-1065 (1) and their prodrugs 5, 6a, and 6b, for antibody-directed enzyme prodrug therapy (ADEPT). The partially hydrogenated seco-CCI-analogue 7 and the corresponding methyl-CCI analogues 8a and 8b were synthesized by alky

Design, Synthesis and Biological Evaluat
Design, Synthesis and Biological Evaluation of Novel Etoposide Analogues as Cytotoxic Agents
✍ Ying-Qian Liu; Hua Yang; Xuan Tian πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 1 views

## Abstract Five novel compounds composed of etoposide and 5‐fluorouracil derivatives joined by an ester linkage were prepared and evaluated for their antitumor potential. Most of these analogues have exhibited promising __in vitro__ cytotoxic activity against cell cultures of murine leukaemia P‐38

Asymmetric Synthesis and Biological Eval
Asymmetric Synthesis and Biological Evaluation of Glycosidic Prodrugs for a Selective Cancer Therapy
✍ Lutzβ€…F. Tietze; J.β€…Marian vonβ€…Hof; Birgit Krewer; Michael MΓΌller; Felix Major; H πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 390 KB

## Abstract A severe limitation in cancer therapy is the often insufficient differentiation between malign and benign tissue using known chemotherapeutics. One approach to decrease side effects is antibody‐directed enzyme prodrug therapy (ADEPT). We have developed new glycosidic prodrugs such as (βˆ’